Chemical inhibitors of EG633640 can exert their inhibitory effects through various mechanisms by targeting specific proteins or enzymes within signaling pathways. Staurosporine, for example, is a broad-spectrum protein kinase inhibitor, which means it can inhibit a range of kinases that EG633640 may rely on for its activation or functionality. By inhibiting these kinases, staurosporine disrupts the phosphorylation events necessary for EG633640's activation. Similarly, Bisindolylmaleimide I targets protein kinase C, an enzyme that plays a critical role in multiple signaling pathways. By inhibiting protein kinase C, Bisindolylmaleimide I can reduce the downstream effects that would otherwise contribute to the functional activity of EG633640. Genistein, a tyrosine kinase inhibitor, can block the phosphorylation of proteins upstream of EG633640, which can lead to a decrease in EG633640's activation.
LY294002 and Wortmannin are both inhibitors of PI3K, and their action can decrease AKT pathway signaling, potentially resulting in the inhibition of EG633640 if it is a downstream effector. Rapamycin targets mTOR, another central protein in signaling pathways, and its inhibition can lead to a decrease in the activity of downstream proteins, including EG633640. PD98059 and U0126 are inhibitors of MEK, which is upstream of ERK; by preventing ERK activation, these inhibitors can lead to reduced signaling through pathways that EG633640 may be involved in. SB203580 and SP600125 inhibit the p38 MAPK and JNK pathways, respectively, which can lead to reduced activity of EG633640 if it is a part of these pathways. PP2 specifically inhibits Src family tyrosine kinases, potentially leading to a decrease in EG633640 activity. Lastly, Y-27632 inhibits Rho-associated kinase (ROCK), which can reduce the activity of EG633640 by affecting the pathways that are regulated by ROCK. Through these diverse mechanisms, the selected chemical inhibitors can effectively reduce the functional activity of EG633640 by interrupting the signaling cascades it is involved in.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
Staurosporine inhibits protein kinases involved in the signal transduction pathways that EG633640 is part of, leading to the inhibition of EG633640's kinase-dependent functions. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $103.00 $237.00 | 36 | |
Bisindolylmaleimide I selectively inhibits protein kinase C, which is required for the activation of certain pathways that include EG633640, thereby inhibiting EG633640's function. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $26.00 $92.00 $120.00 $310.00 $500.00 $908.00 $1821.00 | 46 | |
Genistein inhibits tyrosine kinases which could be upstream of EG633640, and this inhibition would reduce phosphorylation events that activate EG633640. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002 is a PI3K inhibitor, and by inhibiting PI3K it would reduce AKT activation, potentially inhibiting downstream proteins such as EG633640. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Wortmannin is also a PI3K inhibitor, which would decrease AKT pathway signaling, thus inhibiting the activation of EG633640 if EG633640 is a downstream effector. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin inhibits mTOR, which can inhibit downstream signaling pathways including those that may involve EG633640, leading to functional inhibition of EG633640. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
PD98059 is an MEK inhibitor, which would prevent the activation of ERK, potentially inhibiting downstream proteins such as EG633640 if it is involved in this pathway. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
U0126 is another MEK inhibitor, which would similarly prevent ERK activation, thus inhibiting downstream effects on EG633640 if it is part of the MEK/ERK pathway. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
SB203580 inhibits p38 MAPK, which could inhibit downstream proteins that are part of this signaling pathway, including EG633640. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 inhibits JNK, which could inhibit downstream signaling pathways that EG633640 is part of, resulting in functional inhibition of EG633640. | ||||||